Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
BIO-key International ( (BKYI) ) has issued an announcement.
On September 30, 2025, BIO-key International, Inc. entered into a note purchase agreement with Streeterville Capital, LLC, resulting in the issuance of a $1,130,000 senior secured promissory note. The company received $1,000,000 in funding after deductions, which will be used for general working capital. The note, due in eighteen months, carries a nine percent interest rate and includes various terms for repayment and default conditions, impacting the company’s financial obligations and operational flexibility.
The most recent analyst rating on (BKYI) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on BIO-key International stock, see the BKYI Stock Forecast page.
Spark’s Take on BKYI Stock
According to Spark, TipRanks’ AI Analyst, BKYI is a Neutral.
BIO-key International’s overall stock score reflects significant financial challenges, with ongoing losses and cash flow issues being the most impactful factors. While the earnings call showed positive revenue growth and strategic expansions, the valuation remains a concern due to negative profitability metrics. Technical analysis indicates limited momentum, further weighing on the stock’s outlook.
To see Spark’s full report on BKYI stock, click here.
More about BIO-key International
BIO-key International, Inc. operates in the cybersecurity industry, focusing on providing identity and access management solutions. The company specializes in biometric authentication technologies aimed at enhancing security for enterprises and government agencies.
Average Trading Volume: 135,041
Technical Sentiment Signal: Sell
Current Market Cap: $5.46M
Learn more about BKYI stock on TipRanks’ Stock Analysis page.